United Therapeutics | UTHR - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
Amarin USD 18.97M 1.03M 2025-12
Ardelyx USD 102.27M 26.35M 2026-03
Baxter International USD 735M 7M 2026-06
Bayer EUR 3.96B 267M 2026-06
BioCryst Pharmaceuticals USD 63.98M 31.8M 2026-06
Biogen USD 709.7M 155.4M 2026-06
BioMarin Pharmaceutical USD 395.55M 137.27M 2026-06
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.19B 75M 2026-06
Halozyme Therapeutics USD 57M 10.71M 2026-06
Insmed USD 247.47M 208K 2026-06
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
J&J USD 6.25B 168M 2026-09
Lexicon Pharmaceuticals USD 3.98M 195K 2025-12
Moderna USD 216M 43M 2026-06
Omeros USD 11.32M 2.48M 2024-09
Pfizer USD 3.41B 496M 2026-06
PTC Therapeutics USD 73.89M 13.31M 2026-03
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sarepta Therapeutics USD 107.6M 53.57M 2026-06
Teva Pharmaceutical Industries USD 1.03B 34M 2026-06
United Therapeutics USD 206.7M 50.1M 2026-06
Vertex Pharmaceuticals USD 582.2M 88.5M 2026-06